Can Rheumatic Fever Relapse?
Yes, acute rheumatic fever can absolutely relapse—patients with a previous attack who develop Group A streptococcal pharyngitis are at very high risk for recurrent episodes, which can worsen existing rheumatic heart disease or cause new cardiac damage even in those without initial cardiac involvement. 1
Why Recurrence is a Critical Concern
Recurrent attacks carry substantial morbidity risk: Each recurrence can progressively worsen rheumatic heart disease severity, and less commonly can cause new-onset cardiac disease in patients who escaped carditis during their first episode. 1
Recurrence can occur even with optimal treatment: Group A streptococcal infections need not be symptomatic to trigger a recurrence, and rheumatic fever can recur even when a symptomatic pharyngitis is treated appropriately. 1
Risk increases with multiple prior attacks: The likelihood of recurrence escalates with each previous episode, making secondary prophylaxis increasingly critical. 1
Clinical presentation differs in recurrent cases: Recurrent episodes present more commonly with shortness of breath, palpitations, and aortic regurgitation, whereas first episodes more often manifest with arthritis. 2 Audible murmurs corresponding to echocardiographic regurgitation are present in 100% of recurrent cases versus only 61.5% in first episodes. 2
Mortality risk is concentrated in recurrent disease: All deaths in one pediatric cohort occurred exclusively in the recurrent rheumatic fever group, underscoring the life-threatening nature of repeated attacks. 2
Secondary Prophylaxis Regimen
Benzathine penicillin G 1.2 million units intramuscularly every 4 weeks is the gold-standard prophylaxis regimen (Class I, Level A evidence) and is approximately 10-fold more effective than oral antibiotics at preventing recurrence. 3, 4, 5, 6
First-Line Regimen
Standard dosing: Benzathine penicillin G 1.2 million units IM every 4 weeks for all patients with prior rheumatic fever or rheumatic heart disease. 3, 4, 5
High-risk modification: For patients at elevated risk (prior recurrence despite adherence, ongoing high streptococcal exposure, or documented recurrence), shorten the interval to every 3 weeks to maintain more consistent protective penicillin levels. 3, 4, 5
Initial treatment: Before starting long-term prophylaxis, administer a full therapeutic course of penicillin to eradicate any residual Group A Streptococcus, even if throat culture is negative. 1, 3
Alternative Regimens for Penicillin Allergy
Second-line: Oral penicillin V 250 mg twice daily for children or 500 mg 2-3 times daily for adolescents/adults. 3, 5
Third-line: Sulfadiazine 1 gram orally once daily for adults or 0.5 gram once daily for patients weighing ≤27 kg. 3, 4, 5
Last resort: Macrolide or azalide antibiotics only when allergic to both penicillin and sulfadiazine, but avoid in patients taking cytochrome P450 3A inhibitors (azole antifungals, HIV protease inhibitors, certain SSRIs). 3, 4, 7
Duration of Secondary Prophylaxis
The duration depends on cardiac involvement and residual valvular disease:
| Clinical Scenario | Duration (whichever is longer) |
|---|---|
| Rheumatic fever WITH carditis AND residual valvular disease | 10 years after last attack OR until age 40 years (sometimes lifelong) [1,3,4] |
| Rheumatic fever WITH carditis but NO residual valvular disease | 10 years after last attack OR until age 21 years [1,3,4] |
| Rheumatic fever WITHOUT carditis | 5 years after last attack OR until age 21 years [1,3,4] |
| High-risk occupational/community exposure (teachers, daycare workers, healthcare workers, parents of young children, military recruits, crowded living situations) | Consider lifelong prophylaxis [1,3,4] |
Critical Management Pitfalls to Avoid
Never discontinue prophylaxis prematurely: Even if the patient feels well, has a normal echocardiogram, or has undergone valve replacement surgery, prophylaxis must continue because surgery does not eliminate the risk of recurrent acute rheumatic fever. 4, 5
Do not stop at arbitrary age cutoffs: Always evaluate individual risk factors including ongoing streptococcal exposure, severity of valvular disease, and time since the last attack before discontinuing prophylaxis. 4, 5
Recognize adherence failures: Children who missed even one prophylaxis dose within the last 6 months had significantly higher Group A streptococcal throat culture positivity rates, and those receiving injections every 4 weeks had higher positivity rates than those receiving 2-week intervals. 8
Address family members promptly: Streptococcal infections in family members of patients with current or previous rheumatic fever should be treated immediately (Class I, Level B evidence). 1
Modified Diagnostic Criteria for Recurrent Episodes
Patients with documented prior rheumatic fever or established rheumatic heart disease require less stringent criteria for diagnosing recurrence: With documented Group A streptococcal infection, 2 major criteria OR 1 major plus 2 minor criteria OR 3 minor manifestations may be sufficient for presumptive diagnosis (Class IIb, Level C evidence). 1
When only minor manifestations are present, exclude other more likely causes before diagnosing recurrence (Class I, Level C evidence). 1